XML 37 R25.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue from Contract with Customer (Tables)
 9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of revenues by geographic region
The Company’s net revenues by geographic region, based on the patient’s location are summarized as follows:
Three months ended September 30,Nine months ended September 30,Year ended December 31,
 20240202320242023
2023
United States$98,345 $86,243 $284,599 $258,429 $349,743 
International markets:
Germany16,990 14,683 47,834 45,547 60,210 
France 15,243 4,157 39,998 4,157 11,736 
Japan8,581 7,588 24,062 24,118 31,668 
Other international markets11,311 7,894 32,053 24,481 32,757 
International markets - Total52,125 34,322 143,947 98,303 136,371 
Greater China (1)
4,625 6,756 15,408 18,822 23,224 
Total net revenues$155,095 $127,321 $443,954 $375,554 $509,338 
(1) For additional information, see Notes 12 and 13 to the Consolidated Financial Statements in the 2023 10-K.
Revenue recognized according performance period
The Company's net revenues by performance period are as follows:
Three months ended September 30,Nine months ended September 30,Year ended December 31,
 202402023202420232023
Net revenues recognized in the reporting period from performance obligations satisfied in:
Reporting period$142,960 $125,704 $417,023 $362,636 $492,089 
Previous periods12,135 1,617 26,931 12,918 17,249 
Total net revenues$155,095 $127,321 $443,954 $375,554 $509,338 
Trade receivables, unbilled receivables and contract liabilities
The following table provides information about trade receivables, unbilled receivables and contract liabilities from contracts with customers:
September 30,
2024		December 31,
2023
 UnauditedAudited
Trade receivables$61,316 $56,970 
Unbilled receivables$5,744 $4,251 
Deferred revenues (short-term contract liabilities)(14,866)(16,224)